Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the U.S. financial markets. The announcement will be ...

Swiss-headquartered Sandoz, which spun off from Novartis in 2023, is one of the world's largest makers of generic and ...

Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number of jobs created to 750 and the total investment in Central Ohio to over $1.4 ...

Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight.Stay Ahead of the Market: Discover outperforming stocks and invest ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

NPR's Morning Edition explores this dynamic in a new series, The State of the First Amendment. April 15, 2025 • An administrative judge at the federal agency that enforces U.S. workplace anti ...

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...

(RTTNews) - Sandoz (SDZNY) has initiated an antitrust lawsuit in the United States against Amgen, Inc. (AMGN), accusing the company of maintaining its dominant market position for the blockbuster ...

ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United ...

The therapy was engineered by researchers at Amgen. © 1996-2025 Amgen Inc. All Rights Reserved. Amgen’s global Phase III DeLLphi-304 trial of Imdelltra (tarlatamab ...

Amaya went 2-for-3 with a home run, three total runs and three total RBI against the Dodgers in a 16-0 victory Saturday. Amaya didn't start the contest, but he was moved into the DH role after ...

Amgen When Dr. David Reese, Amgen’s first chief technology officer, set about hiring a head of artificial intelligence last year, he looked at people who’d worked in consumer products, finance ...